Designers are utilizing an array of programmable or configurable ICs to keep pace with rapidly changing technology and AI.
Vyriad announced $25M final tranche of its Series B to support the first-in-human testing of VV169, Vyriad’s in vivo CAR-T candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback